Interleukin enhancer-binding factor 3 (ILF3) (Internal Region) Antikörper
-
- Target Alle Interleukin enhancer-binding factor 3 (ILF3) Antikörper anzeigen
- Interleukin enhancer-binding factor 3 (ILF3)
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Verwendungszweck
- ILF3
- Sequenz
- QKPSYGSGYQ SHQGQ
- Spezifität
- This antibody is expected to recognize isoforms a (NP_036350.2) and d (NP_060090.2).
- Kreuzreaktivität
- Rind (Kuh), Hund, Human, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Isotyp
- IgG
- Top Product
- Discover our top product ILF3 Primärantikörper
-
-
- Applikationshinweise
-
Immunohistochemistry: In paraffin embedded Human Kidney shows nuclear staining in convoluted tubules. Recommended concentration, 2-4 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:32000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- Interleukin enhancer-binding factor 3 (ILF3)
- Andere Bezeichnung
- ILF3 (ILF3 Produkte)
- Hintergrund
- ILF3, interleukin enhancer binding factor 3, 90 kDa, DRBF, MMP4, MPHOSPH4, MPP4, NF-AT-90, NF90, NFAR, TCP80, M-phase phosphoprotein 4, dsRNA binding protein NFAR-2/MPP4, interleukin enhancer binding factor 3, nuclear factor associated with dsRNA, nuclear
- Gen-ID
- 3609
- NCBI Accession
- NP_036350, NP_060090
- Pathways
- M Phase
-